Papilloma Clinical Trial
Official title:
A Phase I/II Evaluation of Cidofovir Therapy For Recurrent Laryngeal Papillomatosis in Children
The purpose of this study is to see what dose of the drug cidofovir is safe to treat
laryngeal papillomatosis (warts in the throat which occur over and over) in children.
Laryngeal papillomatosis is caused by infection with a virus called human papillomavirus
(HPV). At present, there is no approved drug to treat this infection. However, cidofovir is
a drug effective against several viruses. Cidofovir may be able to attack the HPV virus.
This study tests the safety of giving this drug to children.
Your child will be assigned randomly (like tossing a coin) to receive either cidofovir or placebo (an inactive substance). Neither you nor your doctor will know which your child is receiving. Your child will undergo a total of 6 bronchoscopic procedures, which involves placing a tube down your child's throat so that the warts can be seen and treated. The warts will be removed by laser or other procedures and the study drug injected. Study drug will be injected at the sites of all newly removed warts and warts which were removed during earlier study visits. This procedure will be performed every other week. Blood and urine tests will also be performed at this time. Your child will be under general anesthesia during each procedure and will be in the surgery unit for about 6 to 8 hours. Your child will also have to be seen by the doctor 2 days after the procedure. Your child will be followed for a total of 5 years to make sure he/she develops normally and to monitor any side effects of cidofovir. Follow-up visits will take place at Months 3, 6, and then once every 6 months through Year 5. If necessary, laser or other procedures will be performed at these visits to remove any warts. ;
Masking: Double-Blind, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01234480 -
Intended Use Study of the BD SurePath Plus™ Pap
|
||
Terminated |
NCT00591305 -
New Therapy of Laryngeal Papilloma In Children
|
N/A | |
Completed |
NCT00038714 -
A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis
|
Phase 2 | |
Completed |
NCT00006444 -
The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women
|
N/A | |
Withdrawn |
NCT01175499 -
Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive Tract
|
N/A | |
Completed |
NCT05625308 -
Effect of Natural Compounds on the Severity of HPV-induced Cervical Lesions
|
N/A | |
Completed |
NCT01827423 -
Squamous Cell Carcinoma Antigen Analysis at the University Hospital Ostrava
|
N/A | |
Completed |
NCT00001603 -
The Effects of Upper Airway and Digestive Tract Tumors on the Immune System
|
N/A | |
Recruiting |
NCT05797246 -
Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)
|
Phase 2 |